Page last updated: 2024-10-28

hydralazine and Systolic Heart Failure

hydralazine has been researched along with Systolic Heart Failure in 4 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lim, WY1
Woldman, S1
Münzel, T1
Gori, T1
Keaney, JF1
Maack, C1
Daiber, A1
Rame, JE1
Tam, SW1
McNamara, D1
Worcel, M1
Sabolinski, ML1
Wu, AH1
Dries, DL1
Pan, L1
Payne, J1
Clark, M1

Reviews

2 reviews available for hydralazine and Systolic Heart Failure

ArticleYear
Pharmacological management of chronic heart failure: old drugs, new drugs and new indications.
    British journal of hospital medicine (London, England : 2005), 2013, Volume: 74, Issue:2

    Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibit

2013
Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications.
    European heart journal, 2015, Oct-07, Volume: 36, Issue:38

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Cardiovascular System; Drug Therapy, Combina

2015

Other Studies

2 other studies available for hydralazine and Systolic Heart Failure

ArticleYear
Dysfunctional corin i555(p568) allele is associated with impaired brain natriuretic peptide processing and adverse outcomes in blacks with systolic heart failure: results from the Genetic Risk Assessment in Heart Failure substudy.
    Circulation. Heart failure, 2009, Volume: 2, Issue:6

    Topics: Black or African American; Cardiovascular Agents; Double-Blind Method; Drug Combinations; Female; Ge

2009
Question: does isosorbide dinitrate/hydralazine therapy benefit systolic heart failure patients with renal insufficiency?
    The Journal of the Oklahoma State Medical Association, 2011, Volume: 104, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Drug Combinations; Evidence-Based M

2011